The pharma company said asundexian, when combined with antiplatelet therapy, lowered the risk of stroke in patients during ...

An astounding domestic and continental double can be considered a realistic goal for Arteta's title chasers, who have been ...

A largely Portuguese team of match officials will oversee proceedings between Manchester City and Bayer Leverkusen on Tuesday night.Pep Guardiola and his players will be aiming to bounce back ...

Bayer shares surge after its asundexian stroke drug shows positive Phase III results, offering a key boost to its pipeline ...

The Chinese e-commerce leader said its Qwen artificial-intelligence app drew more than 10 million downloads i ...

The articles, information, and content displayed on this webpage may include materials prepared and provided by third parties. Such third-party content is offered for informational purposes ...

Manchester City were beaten at Newcastle at the weekend but have won three out of four undefeated Champions League games this ...

Bayer stock jumped on Monday after the German healthcare company said a late-stage stroke drug trial achieved its goals.

Investing.com -- Bayer’s (ETR:BAYGN) experimental stroke drug could generate €3 billion in annual sales after successful trial results that Goldman Sachs analyst James Quigley called "transformational ...

Shares in Bayer jumped more than 8% on Monday after initial clinical trial results turned around the fortunes of a key ...

Stuttgart are bracing for a decisive summer as interest intensifies in Angelo Stiller, Bundesliga’s breakout deep-lying ...

Manchester City face Bayer Leverkusen in the Champions League on Tuesday - as they aim to move a step closer to securing a ...